“A Critical Review on Bioanalytical Methods Impurity Profiling, Degradation Study of Empagliflozin and Linagliptin ”, Journal of Pharmaceutical Negative Results, pp. 3831–3841, Feb. 2023, doi: 10.47750/pnr.2022.13.S08.478.